Terconazole News
Perrigo Company Announces Approval For Terconazole Suppositories
The Perrigo Company (Nasdaq: PRGO; TASE) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market terconazole vaginal suppositories, 80 mg.
Vaginal Candida (yeast) Infections - FDA Approval For Terconazole Suppositories
The Perrigo Company (Nasdaq: PRGO; TASE) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market terconazole vaginal suppositories, 80 mg.
Taro Receives Approval for Terconazole Vaginal Cream, 0.4% ANDA; Generic Equivalent to Terazol-R- 7 Vaginal Cream
Taro Pharmaceutical Industries Ltd. (Nasdaq: TARO) and its affiliates and subsidiaries ("Taro") reported today that it has received approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug...
Generic Equivalent to Terazol® 3 Vaginal Cream
Taro’s terconazole vaginal cream, 0.8% is bioequivalent to Ortho-McNeil Pharmaceutical’s Terazol® 3 Vaginal Cream 0.8%.
Terconazole vs. fluconazole for treatment of candidiasis
The triazole antifungal drugs terconazole and fluconazole are more effective than the imidazoles against yeasts causing vulvovaginal candidiasis.